Aquatic Capital Management LLC Vertex Pharmaceuticals Inc Transaction History

Aquatic Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$285.76 - $321.48 $7.03 Million - $7.91 Million	24,600 New	24,600 $7.1 Million
Q2 2022 Aug 15, 2022	BUY	$234.96 - $292.55 $234,960 - $292,550	1,000 New	1,000 $282,000
Q1 2022 May 16, 2022	SELL	$221.42 - $260.97 $22,142 - $26,097	-100 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$177.01 - $223.45 $17,701 - $22,345	100 New	100 $22,000

1,707

226M

1.2M

1.59M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $122B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Aquatic Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Aquatic Capital Management LLC with notifications on news.